A carregar...
Publicação
PALOMA-3 clinical trial: is there a significant benefit in overall survival for breast cancer? Is it worth it?
| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 1.23 MB | Adobe PDF |
Orientador(es)
Resumo(s)
Breast cancer is a very important disease in terms of public health worldwide. Several patients are diagnosed and follow to a progressive disease every year. CDK4/6 inhibitors (CDKi) were a paradigm shift in the
treatment of hormone receptor-positive (HR+), HER2-negative advanced breast cancer (aBC).
Descrição
Palavras-chave
Antineoplastic combined chemotherapy Protocols Breast neoplasms Clinical trials, Phase II as topic Clinical Trials, Phase III as topic Female Humans Treatment outcome
Contexto Educativo
Citação
Editora
Future Medicine